Sign Out
Vinorelbine Tartrate injection should be administered under the supervision of a physician experienced in the use of cancer chemotherapy agents. The product is for intravenous (i.v.) use only. lntrathecal administration of other Vinca Alkaloids has resulted in death.
Severe granulocytopenia resulting in increased susceptibility to infection may occur. Granulocyte counts should be > 1,500 cells/mm3. Prior to the administration of Vinorelbine Tartrate, the dosage should be adjusted according to complete blood counts with differentials obtained on the day of treatment.
Caution: lt is extremely important that the intravenous needle or catheter be properly positioned before Vinorelbine Tartrate is injected. Administration of Vinorelbine Tartrate may result in extravasation causing rarely local tissue necrosis and/or thrombophlebitis.
